Celltrion plans July COVID-19 trial, advances 'super antibody'

Celltrion is aiming to start testing an antibody treatment for COVID-19 in humans in July. The Korean drug developer is working to get the SARS-CoV-2-neutralizing treatment into clinical trials while also advancing a candidate designed to eliminate all related coronavirus strains.